Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arch Pathol Lab Med ; 128(6): 640-4, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15163237

RESUMO

CONTEXT: Cases of fatal hemorrhagic pneumonia need to be investigated for highly contagious viral causes. While not all hemorrhagic pneumonias are caused by very contagious agents, the etiology must be correctly determined in order to administer appropriate patient care. OBJECTIVE: To determine whether chlamydia, paramyxovirus, or mycoplasma was the causative agent in a case of fatal hemorrhagic pneumonia, and to evaluate the possibility that this was the first case of hantavirus pulmonary syndrome in Illinois. DESIGN: Nonroutine virological and molecular analyses were performed on lung tissue taken during an unrestricted autopsy of a patient who died in 2002. SETTING AND PATIENT: An elderly, male, Chicago-area resident with a 3-week history of nonspecific, mild upper respiratory tract infection was admitted for hospital treatment of the respiratory infection and viral myositis without cardiac involvement. The patient became febrile, hypoxic, developed hemorrhagic pneumonia, and died. Because he had proven exposure to mice and had developed hemorrhagic pneumonia, hantavirus pulmonary syndrome was suspected as the cause of death. Mice known to carry hantaviruses live in Illinois, including the Chicago area. INTERVENTIONS: Gatifloxacin and heparin anticoagulation were initiated because community-acquired pneumonia and pulmonary embolism were considered likely etiologies for an acute exacerbation of hypoxemia. RESULTS: Two respiratory pathogens were isolated and identified: Chlamydia pneumoniae and human parainfluenza virus 4a. CONCLUSIONS: A mixed (polymicrobial) infection contributed to the patient's death. Hemorrhage was likely a result of anticoagulation therapy superimposed on lung tissues damaged by pneumonia. The uncommon nature of this case and the pathogens involved underscore the challenges in infection control and clinical evaluation that hospitals will face when confronted with possibly new and potentially deadly communicable diseases.


Assuntos
Infecções por Chlamydophila/microbiologia , Chlamydophila pneumoniae/isolamento & purificação , Vírus da Parainfluenza 4 Humana/isolamento & purificação , Pneumonia Bacteriana/microbiologia , Pneumonia Viral/virologia , Infecções por Rubulavirus/virologia , Idoso , Sequência de Aminoácidos , Sequência de Bases , Infecções por Chlamydophila/complicações , Infecções por Chlamydophila/diagnóstico , DNA Viral/química , Evolução Fatal , Síndrome Pulmonar por Hantavirus/diagnóstico , Hemorragia/microbiologia , Hemorragia/virologia , Humanos , Masculino , Dados de Sequência Molecular , Vírus da Parainfluenza 4 Humana/genética , Pneumonia , Pneumonia Bacteriana/complicações , Pneumonia Bacteriana/diagnóstico , Pneumonia Viral/complicações , Pneumonia Viral/diagnóstico , Infecções por Rubulavirus/complicações , Infecções por Rubulavirus/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...